Skip to main content
. 2023 Sep 22;8(12):2690–2700. doi: 10.1016/j.ekir.2023.09.019

Table 2.

Compairsons between the pre-TF2 and TF2 cohorts

All patients who received CRRT (N = 178)
Variable Pre-TF2 (n = 71) Post-TF2 (n = 107) P-value
Pre-CRRT patient demographics and fluid status
Patient age (yrs) Median [IQR] 8.1 [2.0, 15.1] 10.3 [2.3, 17.0] 0.37
Patient PICU admission weight (kg) Median [IQR] 26.5 [13.3, 49.0] 30.7 [13.2, 59.0] 0.21
PRISM III score at PICU admission Median [IQR] 12 [8.0, 16] 10 [5.0, 17] 0.23
Renal angina index at 12 hours of PICU admissiona Median [IQR] 8 [6, 24] 15 [6, 40] 0.26
Time from PICU admission to CRRT initiation (d) Median [IQR] 4.5 [2.5, 12.5] 2.3 [1.4, 5.8] 0.002
Fluid accumulation from PICU admission to CRRT initiation (%) Median [IQR] 12.1 [4.9, 20.3] 4.1 [0.6, 12.2] 0.0008
PICU fluid accumulation >15% at CRRT initiation Yes 26 (36.6%) 22 (20.6%) 0.02
PICU fluid accumulation >20% at CRRT initiation Yes 18 (25.4%) 20 (18.7%) 0.35
Patient outcome measures Pre-TF2 (n = 71) Post-TF2 (n = 107)
Survival to CRRT D/C Yes 48 (67.6%) 74 (69.2%) 0.87
Survival to PICU D/C Yes 33 (46.5%) 70 (65.4%) 0.02
Pre-TF2 (n = 48) Post-TF2 (n = 74)
CRRT duration among CRRT survivors (d) Median [IQR] 5.8 [2.9, 12.2] 4.0 [1.9, 9.7] 0.06
Pre-TF2 (n = 33) Post-TF2 (n = 70)
PICU LOS after CRRT D/C among PICU survivors (d) Median [IQR] 8.6 [4.5, 13] 2.6 [0.7, 8.6] 0.002
Total PICU length of stay among PICU survivors (d) Median [IQR] 24 [12, 39] 13 [6, 26] 0.02
Patients who received CRRT within 14 days of PICU admission (N = 151)
Variable Pre-TF2 (n = 56) Post-TF2 (n = 95) P-value
Pre-CRRT patient demographics and fluid status
PRISM III score at PICU admission Median [IQR] 12 [8.5, 16] 10 [6, 17] 0.28
Time from PICU admission to CRRT initiation (d) Median [IQR] 2.7 [1.8, 6.1] 1.7 [1.1, 3.9] 0.006
Fluid accumulation from PICU admission to CRRT initiation (%) Median [IQR] 11.7 [4.8, 20.4] 3.7 [0.5, 12.1] 0.0004
PICU fluid accumulation >15% at CRRT Initiation Yes 22 (40.0%) 18 (18.9%) 0.007
Patient outcome measures Pre-TF2 (n = 56) Post-TF2 (n = 95)
Survival to CRRT D/C Yes 36 (64.3%) 68 (71.6%) 0.37
Survival to PICU D/C Yes 26 (46.4%) 65 (68.4%) 0.01
Pre-TF2 (n = 36) Post-TF2 (n = 68)
CRRT duration among CRRT survivors (d) Median [IQR] 5.8 [3.2, 12.2] 4.2 [2.2, 9.7] 0.07
Pre-TF2 (n = 26) Post-TF2 (n = 65)
PICU LOS after CRRT D/C among PICU survivors (d) Median [IQR] 7.9 [2.5, 11] 2.5 [0.6, 6.5] 0.01
Total PICU length of stay among PICU survivors (d) Median [IQR] 17 [9, 31] 11 [6, 20] 0.08

CRRT, continuous renal replacement therapy; IQR, interquartile range; PICU, pediatric intensive care unit; PRISM, pediatric risk of mortality; TF2, TAKING FOCUS 2.

a

n = 61 for pre-TF2 and 86 for TF2 eras as patients <3 months of age or with ESRD do not receive an RAI calculation.